Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00194298 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FDG-PET Imaging in Complicated Diabetic Foot

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Notable

    Primary and study completion dates: Feb 2026 to Feb 2027

    Study Statusv15

  2. Notable

    Primary and study completion dates: Feb 2025 to Feb 2026

    Study Statusv14

  3. Notable

    Primary and study completion dates: Feb 2024 to Feb 2025

    Study Statusv13

  4. Notable

    Primary and study completion dates: Feb 2023 to Feb 2024

    Study Statusv12

  5. Notable

    Primary and study completion dates: Feb 2022 to Feb 2023

    Study Statusv11

Show 9 earlier versions

  1. Notable

    Primary and study completion dates: Jan 2021 to Feb 2022

    Study Statusv10

  2. Notable

    Primary and study completion dates: Jan 2020 to Jan 2021

    Study Statusv9

  3. Minor

    2 amendments

    2 re-verifications since 2018-05-03, no change to tracked fields

    v7-v8

  4. Notable

    Primary completion date: Jan 2017 to Jan 2020

    Completion date: Jan 2020

    Study Statusv6

  5. Notable

    Primary completion date: Jan 2016 to Jan 2017

    Study Statusv5

  6. Notable

    Primary completion date: Jan 2014 to Jan 2016

    Study Statusv4

  7. Notable

    Phase: Phase 2/3 to Not specified

    Trial status: Recruiting to Active, Not Recruiting; Primary completion date: Jan 2014; Study description revised; and 1 more

    Show all 5 changes in this update
    • Notable Phase: Phase 2/3 to Not specified
    • Minor Trial status: Recruiting to Active, Not Recruiting
    • Minor Primary completion date: Jan 2014
    • Minor Study description revised
      Show what changed
      [...] is, myositis, mastitis, vasculitis, deep venous thrombosis, thyroidititisthyroiditis and other infections including those encountered in orthope [...]
    • Minor Site details revised

    Study Status, Sponsor/Collaborators, Study Description, Conditions, Study Design, Outcome Measures, Eligibility, Contacts/Locationsv3

  8. Minor

    Study Status

    Re-verified, no change to tracked fields

    v2

  1. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main objective of the proposed research study is to determine the potential utilization of \[18-F\] Fluorodeoxyglucose (FDG) positron emission tomography (PET) in patients with complicated diabetic foot, especially in the diagnosis or exclusion of osteomyelitis in this setting. We intend to validate and establish the necessary criteria for making such a diagnosis and determine the accuracy of the technique through comparison with other existing modalities, including MRI, and patient outcome. We expect that at the completion of the proposed research, the role of these powerful imaging modalities will be clearly defined in the management of patients with this challenging and serious complication.
Trial Details
NCT Number NCT00194298
Lead Sponsor University of Pennsylvania
Collaborators: National Institutes of Health (NIH)
Conditions Diabetic Foot Disease
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov